Table 2 The prognostic value of contractility in the stress echo lab
From: Myocardial contractility in the stress echo lab: from pathophysiological toy to clinical tool
Author, year | Stress | Pts (n) | Inclusion criteria | LVEF | Median follow-up (months) | Best prognostic PVR cut-off | Considered events | Events n (%) | PPV | NPV |
|---|---|---|---|---|---|---|---|---|---|---|
Grosu A et al., 2005 [7] | DOB | 95 | Medically treated pts with LV dysfunction | 40±15% | 18 | <0.2 mmHg/ml/m2 | Death, HF | 18 (19%) | 77% | 89% |
Otasevic P et al., 2006 [20] | DOB | 59 | Idiopathic dilated cardiomyopathy | 19±8% | 60 | <0.33 mmHg/ml/m2 | Death | 27 (46%) | 62% | 84% |
Bombardini T et al., 2008 [15] | EX | 99 | Medically treated pts with negative stress | 47±14% | 21 | <2.2 mmHg/ml/m2 | Death, HF, ↑NYHA | 29 (29%) | 62% | 98% |
Agricola E et al., 2008 [23] | EX | 37 | Functional MR in LV dysfunction | 29±7% | 20 | <0.4 mmHg/ml/m2 | Death | 8 (22%) | 35% | 93% |
Ciampi Q et al., 2010 [24] | DOB | 72 | Identification of CRT responders | 26±6% | 12 | <0.7 mmHg/ml/m2 | Death, HF | 22 (31%) | 40% | 91% |
Bombardini T et al., 2011 [17] | DIP | 16 | Recipients of older donor hearts | 56±6% | 14 | <0 mmHg/ml/m2 | Death | 2 (13%) | 50% | 94% |
Bombardini T et al., 2013 [25] | EX | 172 | Followed-up Pts with negative stress | 53±14% | 32 | <1.34 mmHg/ml/m2 | Death, HF | 29 | 55% | 96% |
DIP | 482 |  | 50±17% | 21 | <0.46 mmHg/ml/m2 | Death, HF | 68 | 24% | 97% | |
DOB | 237 |  | 39±15% | 6 | <0.56 mmHg/ml/m2 | Death, HF | 37 | 40% | 94% | |
Cortigiani L et al., 2009 [19] | DOB | 233 | Diabetics with negative stress | 52±10% | 18 | <12 mmHg/ml/m2 | Death, PCI/CABG | 62 (27%) | 36% | 83% |